Time to systemic metastases in patients with posterior uveal melanoma

Cancer Investigation

Volumn 15, Issue 2, 1997, Pages 98-105

  Sato, Takami ^a,c   Babazono, Akira ^b   Shields, Jerry A ^c   Shields, Carol L ^c   De Potter, Patrick ^c   Mastrangelo, Michael J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b KYUSHU UNIVERSITY   (Japan)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE;

ADULT; AGED; ARTICLE; EYE TUMOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; UVEA MELANOMA;

EID: 0030959483     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909709115761     Document Type: Article

References (35)

1. Scotto J, Fraumeni JF Jr, Lee LA: Melanomas of the eye and other noncutaneous siles: Epidemiologic aspect. JNCI 56:489-491, 1976.
2. Weinstock MA: Epidemiology of melanoma. In: Current Research and Clinical Management of Melanoma, edited by L Nathanson, Boston, Kluwer Academic Publishers, 1993, pp 29-56.
3. Shields JA, Shields CL: Management of posterior uveal melanoma. In: Intraocular Tumors: A Text and Atlas, edited by JA Shields, CL Shields, Philadelphia, WB Saunders, 1992, pp 171-205.
4. Jensen OA: Malignant melanoma of uvea in Denmark 1943-52. Acta Ophthalmol 75(Suppl):210-220, 1963.
5. Brown D, Boniuk M, Font R: Diffuse malignant melanoma of iris with metastases. Surv Ophthalmol 34:357-364, 1990.
6. Shields, JA: Management of uveal melanoma. A continuing dilemma. Cancer 72:2067-2068, 1993.
7. Albert DM, Niffenegger AS, Willson JK: Treatment of melaslatic uveal melanoma: Review and recommendations. Surv Ophthalmol 36:429-438, 1992.
8. Callender GR, Wilder HC, Ash JE: Five-hundred cases of melanoma of the choroid and the ciliary body followed five years or longer. Am J Ophthalmol 25:962-967, 1942.
9. Paul EV, Parnell BL, Fraker M: Prognosis of malignant melanoma of the choroid and ciliary body. Int Ophthalmol Clin 2:387-402, 1962.
10. McLean IW, Foster WD, Zimmerman LE: Prognostic factors in small malignant melanoma of choroid and ciliary body. Arch Ophthalmol 95:48-58, 1977.
11. McLean IW, Gamel JW: Prediction of metastasis of uveal melanoma: Comparison of morphometric determination of nucleolar size and spectrophotometric determination of DNA. Invest Ophthalmol Vis Sci 29:507-511, 1988.
12. Augsburger, J, Gamel, J: Clinical prognostic factors in patients with posterior uveal malignant melanoma. Cancer 66:1596-1600, 1990.
13. Seddon JM, Albert DM,Lavin PT, et al: A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol 101:1894-1899, 1983.
14. Weinhaus RS, Seddon JM, Albert DM, et al: Prognostic factor study of survival after enucleation for juxapapillary melanoma. Arch Ophthalmol 103:1673-1677, 1985.
15. Donders PC: Malignant melanoma of the choroid. Trans Ophthalmol Soc UK 93:745-751, 1973.
16. Folberg R, Rummelt V, Ginderdeuren RPV, et al: The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 100:1389-1398, 1993.
17. Schultz S, Kane M, Roush R, et al: Time to recurrence varies inversely with thickness in clinical stage I cutaneous melanoma. Surg Gynecd Obstet 171:393-397, 1990.
18. Gamel J, McLean I, McCurdy J: Biologic distinction between cure and time to death in 2892 patients with intraocular melanoma. Cancer 71:2299-2305, 1992
19. Warren RM: Prognosis of malignant melanoma of the choroid and ciliary body. In: Current Concept in Ophthalmology, Vol 4, edited by FC Blodi, St. Louis, CV Mosby, 1974, p 160.
20. Katz MH, Hauck WW: Proportional hazards (Cox) regression. J Gen Intern Med 8:702-711, 1993.
21. Gragoudas ES, Egan KM, Seddon JM, et al: Survival of patients with metastases from uveal melanoma. Ophthalmology 98:383-390, 1991.
22. Bedikian AY, Kantarjian H, Young SE, et al: Prognosis in metastatic choroidal melanoma. South Med J 74:574-577, 1981.
23. Rajpal S, Moore R, Karakousis CP: Survival in meiastatic ocular melanoma. Cancer 52:334-336, 1983.
24. Einhorn LH, Burgess MA, Gottlicb JA: Metastatic patterns of choroidal melanoma. Cancer 34:1001-1004, 1974.
25. Hirokawa K: Understanding the mechanism of the age-related decline in immune function. Nut Rev 50:361-366, 1992.
26. Chandra RK: Nutrition and immunity in the elderly. Nutr Rev 50:367-371, 1992.
27. Fisher RI, Neifeld JP, Lippraan ME: Estrogen receptors in human malignant melanoma. Lancet 2:337-338, 1976.
28. Feucht KA, Walker MJ, Das Gupta TK, et al: Effect of 17β-estradiol on the growth of estrogen receptor-positive human melanoma in vitro and in athymic mice. Cancer Res 48:7093-7101, 1988.
29. Seddon JM, MacLaughlin DT, Albert DM, et al: Uveal melanomas presenting during pregnancy and the investigation of oestrogen receptors in melanoma. Br J Ophthalmol 66:695-704, 1982.
30. Shammas FS, Blodi FC: Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol 95:63-69, 1977.
31. Diener-West M, Hawkins BS, Markowitz JA, et al: A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol 110:245-250, 1992.
32. Breslow A: Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 190:902-908, 1970.
33. Wanebo HJ, Woodruff J, Fortner JG: Malignant melanoma of the extremities: A clinicopathologic study using levels of invasion (microstage). Cancer 35:666-676, 1975.
34. Pyrhonen S, Hahka-Kemppinen M, Muhonen T: A promising inlerferon plus four-drug chemotherapy regimen for metastatic melanoma. J Clin Oncol 10:1919-1926, 1992.
35. Nathan FE, Sato T, Berd D, et al: Bold + interferon: Effective systemic therapy for metastatic u veal melanoma. Proc Am Soc Clin Oncol 14:410, 1995.